AAAAAA
Results: 1-25/44
Authors:
Mehilli, J
Kastrati, A
Dirschinger, J
Dotzer, F
Schuhlen, H
Fleckenstein, M
Neumann, FJ
Schomig, A
Citation: J. Mehilli et al., A randomized trial comparing the hand-mounted JoStent with the premounted Multi-Link Duet stent in patients with coronary artery disease, CATHET C IN, 54(4), 2001, pp. 414-419
Authors:
Neumann, FJ
Citation: Fj. Neumann, Optimization of microvascular reperfusion in acute myocardial infarction, EUR H J SUP, 3(A), 2001, pp. A21-A25
Authors:
Zohlnhofer, D
Richter, T
Neumann, FJ
Nuhrenberg, T
Wessely, R
Brandl, R
Murr, A
Klein, CA
Baeuerle, PA
Citation: D. Zohlnhofer et al., Transcriptome analysis reveals a role of interferon-gamma in human neointima formation, MOL CELL, 7(5), 2001, pp. 1059-1069
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention
Authors:
Anderson, KM
Califf, RM
Stone, GW
Neumann, FJ
Montalescot, G
Miller, DP
Ferguson, JJ
Willerson, JT
Weisman, HF
Topol, EJ
Citation: Km. Anderson et al., Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention, J AM COL C, 37(8), 2001, pp. 2059-2065
Authors:
Neumann, FJ
Hochholzer, W
Pogatsa-Murray, G
Schomig, A
Gawaz, M
Citation: Fj. Neumann et al., Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting, J AM COL C, 37(5), 2001, pp. 1323-1328
Authors:
Neumann, FJ
Kastrati, A
Miethke, T
Pogatsa-Murray, G
Mehilli, J
Valina, C
Jogethaei, N
da Costa, CP
Wagner, H
Schomig, A
Citation: Fj. Neumann et al., Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial, LANCET, 357(9274), 2001, pp. 2085-2089
Authors:
Cannon, CP
Weintraub, WS
Demopoulos, LA
Vicari, R
Frey, MJ
Lakkis, N
Neumann, FJ
Robertson, DH
DeLucca, PT
DiBattiste, PM
Gibson, CM
Braunwald, E
Citation: Cp. Cannon et al., Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban., N ENG J MED, 344(25), 2001, pp. 1879-1887
Authors:
Topol, EJ
Moliterno, DJ
Herrmann, HC
Powers, ER
Grines, CL
Cohen, DJ
Cohen, EA
Bertrand, M
Neumann, FJ
Stone, GW
DiBattiste, PM
Demopoulos, L
Citation: Ej. Topol et al., Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban andabciximab, for the prevention of ischemic events with percutaneous coronary revascularization., N ENG J MED, 344(25), 2001, pp. 1888-1894
Authors:
Schmitt, C
Lehmann, G
Schmieder, S
Karch, M
Neumann, FJ
Schomig, A
Citation: C. Schmitt et al., Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel - Limitations of ST-segment elevation in standard andextended ECG leads, CHEST, 120(5), 2001, pp. 1540-1546
Authors:
Neumann, FJ
Kastrati, A
Miethke, T
Mehilli, J
Pogatsa-Murray, G
Koch, W
Seyfarth, M
Schomig, A
Citation: Fj. Neumann et al., Previous cytomegalovirus infection and restenosis after coronary stent placement, CIRCULATION, 104(10), 2001, pp. 1135-1139
Authors:
Kastrati, A
Mehilli, J
Dirschinger, J
Dotzer, F
Schuhlen, H
Neumann, FJ
Fleckenstein, M
Pfafferott, C
Seyfarth, M
Schomig, A
Citation: A. Kastrati et al., Intracoronary stenting and angiographic results - Strut thickness effect on restenosis outcome (ISAR-STEREO) trial, CIRCULATION, 103(23), 2001, pp. 2816-2821
Authors:
Zohlnhofer, D
Klein, CA
Richter, T
Brandl, R
Murr, A
Nuhrenberg, T
Schomig, A
Baeuerle, PA
Neumann, FJ
Citation: D. Zohlnhofer et al., Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy - Detection of FK506-binding protein 12 upregulation, CIRCULATION, 103(10), 2001, pp. 1396-1402
Authors:
Ott, I
Andrassy, M
Zieglgansberger, D
Geith, S
Schomig, A
Neumann, FJ
Citation: I. Ott et al., Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1, BLOOD, 97(12), 2001, pp. 3721-3726
Authors:
Koch, W
Bottiger, C
Mehilli, J
von Beckerath, N
Neumann, FJ
Schomig, A
Kastrati, A
Citation: W. Koch et al., Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting, AM J CARD, 88(10), 2001, pp. 1120-1124
Authors:
Kastrati, A
Mehilli, J
Dirschinger, J
Pache, J
Ulm, K
Schuhlen, H
Seyfarth, M
Schmitt, C
Blasini, R
Neumann, FJ
Schomig, A
Citation: A. Kastrati et al., Restenosis after coronary placement of various stent types, AM J CARD, 87(1), 2001, pp. 34-39
Authors:
Kastrati, A
Dirschinger, J
Boekstegers, P
Elezi, S
Schuhlen, H
Pache, J
Steinbeck, G
Schmitt, C
Ulm, K
Neumann, FJ
Schomig, A
Citation: A. Kastrati et al., Influence of stent design on 1-year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients, CATHET C IN, 50(3), 2000, pp. 290-297
Authors:
Zohlnhofer, D
Brand, K
Schipek, K
Pogatsa-Murray, G
Schomig, A
Neumann, FJ
Citation: D. Zohlnhofer et al., Adhesion of monocyte very late antigen-4 to endothelial vascular cell adhesion molecule-1 induces interleukin-1 beta-dependent expression of interleukin-6 in endothelial cells, ART THROM V, 20(2), 2000, pp. 353-359
Authors:
Kastrati, A
Koch, W
Berger, PB
Mehilli, J
Stephenson, K
Neumann, FJ
von Beckerath, N
Bottiger, C
Duff, GW
Schomig, A
Citation: A. Kastrati et al., Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting, J AM COL C, 36(7), 2000, pp. 2168-2173
Authors:
Neumann, FJ
Citation: Fj. Neumann, Roxithromycin for prevention of restenosis after stenting, J AM COL C, 36(1), 2000, pp. 316-317
Authors:
Neumann, FJ
Kastrati, A
Schmitt, C
Blasini, R
Hadamitzky, M
Mehilli, J
Gawaz, M
Schleef, M
Seyfarth, M
Dirschinger, J
Schomig, A
Citation: Fj. Neumann et al., Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction, J AM COL C, 35(4), 2000, pp. 915-921
Authors:
Mehilli, J
Kastrati, A
Dirschinger, J
Bollwein, H
Neumann, FJ
Schomig, A
Citation: J. Mehilli et al., Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting, J AM MED A, 284(14), 2000, pp. 1799-1805
Authors:
Schomig, A
Kastrati, A
Dirschinger, J
Mehilli, J
Schricke, U
Pache, J
Martinoff, S
Neumann, FJ
Schwaiger, M
Citation: A. Schomig et al., Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction, N ENG J MED, 343(6), 2000, pp. 385-391
Authors:
Gawaz, M
Brand, K
Dickfeld, T
Pogatsa-Murray, G
Page, S
Bogner, C
Koch, W
Schomig, A
Neumann, FJ
Citation: M. Gawaz et al., Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis, ATHEROSCLER, 148(1), 2000, pp. 75-85
Authors:
Kastrati, A
Schomig, A
Dirschinger, J
Mehilli, J
Dotzer, F
von Welser, N
Neumann, FJ
Citation: A. Kastrati et al., A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease, CIRCULATION, 102(21), 2000, pp. 2593-2598
Authors:
Kastrati, A
Schomig, A
Dirschinger, J
Mehilli, J
von Welser, N
Pache, J
Schuhlen, H
Schilling, T
Schmitt, C
Neumann, FJ
Citation: A. Kastrati et al., Increased risk of restenosis after placement of gold-coated stents - Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease, CIRCULATION, 101(21), 2000, pp. 2478-2483